Page last updated: 2024-08-22

trimetazidine and 4-methoxyamphetamine

trimetazidine has been researched along with 4-methoxyamphetamine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Challeton, JP; Correges, A; Danchin, N; Ferrari, R; Ford, I; Fox, K; Tendera, M; Widimský, P	1

Trials

1 trial(s) available for trimetazidine and 4-methoxyamphetamine

Article	Year
Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial. Lancet (London, England), 2020, 09-19, Volume: 396, Issue:10254 Topics: Administration, Oral; Africa, Northern; Aged; Angina, Stable; Angina, Unstable; Asia; Case-Control Studies; Coronary Angiography; Death; Europe; Female; Hospitalization; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Placebos; Recurrence; Safety; South America; Treatment Outcome; Trimetazidine; Vasodilator Agents	2020

Article

Year

Efficacy and safety of trimetazidine after percutaneous coronary intervention (ATPCI): a randomised, double-blind, placebo-controlled trial.

Lancet (London, England), 2020, 09-19, Volume: 396, Issue:10254

Topics: Administration, Oral; Africa, Northern; Aged; Angina, Stable; Angina, Unstable; Asia; Case-Control Studies; Coronary Angiography; Death; Europe; Female; Hospitalization; Humans; Male; Middle Aged; Non-ST Elevated Myocardial Infarction; Percutaneous Coronary Intervention; Placebos; Recurrence; Safety; South America; Treatment Outcome; Trimetazidine; Vasodilator Agents

2020